Interactions of Standard Antibody with Australia Antigens in Au Ag-Ab Radioimmunoassay

au ag disease


Human antisera against Australia (Au) antigen have been characterized by liquid-phase radioimmunoassay (RIA) for their precipitation of 125 I-labeled Au antigen. The end-point dilutions of sera (anti-Au) which precipitated 50% of 125 I-Au antigen by RIA correlated well with complement fixation titers but had a much wider range, indicating a greater precision and perhaps a better sensitivity of assay. Anti-Au serum diluted to precipitate 50% of 125 I-labeled Au antigen was used as standard antibody in RIA tests to detect either inhibition or enhancement of the reaction by preincubated mixtures of Au antigen and antibody specimens. Without free Au antigen or antibody in the resultant mixtures there was no inhibition or enhancement; the mixtures presumably contained immunoreactively equivalent proportions of Au antigen and antibody. RIA data for diagnostic specimens indicated an end-point sensitivity which was proportional to the dilution of the standard anti-Au sera used in the test. High concentrations of the standard antibody permitted detectable inhibition of 125 I-Au antigen precipitation at lower antigen specimen concentrations. Similarly, low concentrations of the standard antibody permitted detectable enhancement of 125 I-Au antigen precipitation at lower antibody specimen concentrations. Omitting the standard antibody altogether resulted in a more sensitive RIA for Au antibody in test sera.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1021K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References .

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Aach RD, Grisham JW, Parker CW. Detection of Australia antigen by radioimmunoassay. Proc Natl Acad Sci U S A. 1971 May; 68 (5):1056–1060. [PMC free article ] [PubMed ]
  • Alpers JH, Steward MW, Soothill JF. Differences in immune elimination in inbred mice. The role of low affinity antibody. Clin Exp Immunol. 1972 Sep; 12 (1):121–132. [PMC free article ] [PubMed ]
  • Blumberg BS, Sutnick AI, London WT, Millman I. Australia antigen and hepatitis: a comprehensive review. CRC Crit Rev Clin Lab Sci. 1971 Sep; 2 (3):473–528. [PubMed ]
  • Coller JA, Millman I, Halbherr TC, Blumberg BS. Radioimmunoprecipitation assay for Australia antigen, antibody, and antigen-antibody complexes. Proc Soc Exp Biol Med. 1971 Oct; 138 (1):249–257. [PubMed ]
  • Daugharty H. Immunoprecipitin reaction of influenza virus-antibody complex with anti-IgG. J Immunol. 1971 Sep; 107 (3):802–809. [PubMed ]
  • Dreesman GR, Hollinger FB, McCombs RM, Melnick JL. Production of potent anti-Australia

    antigen sera of high specificity and sensitivity in goats. Infect Immun. 1972 Feb; 5 (2):213–221. [PMC free article ] [PubMed ]

  • Gerin JL, Holland PV, Purcell RH. Australia antigen: large-scale purification from human serum and biochemical studies of its proteins. J Virol. 1971 May; 7 (5):569–576. [PMC free article ] [PubMed ]
  • Ginsberg AL, Bancroft WH, Conrad ME. Simplified and sensitive detection of subtypes of Australia antigen (HB Ag) using a solid-phase radioimmune assay. J Lab Clin Med. 1972 Aug; 80 (2):291–296. [PubMed ]
  • Henney CS, Ishizaka K. Studies on the immunogenicity of antigen-antibody precipitates. 1. The suppressive effect of anti-L and anti-H chain antibodies on the immunogenicity of human gammaG globulin. J Immunol. 1968 Nov; 101 (5):896–904. [PubMed ]
  • Hollinger FB, Vorndam V, Dreesman GR. Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods. J Immunol. 1971 Oct; 107 (4):1099–1111. [PubMed ]
  • Kenyon AJ, Gander JE, Lopez C, Good RA. Isolation of Aleutian mink disease virus by affinity chromatography. Science. 1973 Jan 12; 179 (4069):187–189. [PubMed ]
  • Kissling RE, Barker LF. Evaluation of assay methods for hepatitis-associated antigen. Appl Microbiol. 1972 Jun; 23 (6):1037–1046. [PMC free article ] [PubMed ]
  • Lander JJ, Alter HJ, Purcell RH. Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol. 1971 May; 106 (5):1166–1171. [PubMed ]
  • Ling CM, Irace H, Decker R, Overby LR. Hepatitis B virus antigen: validation and immunologic characterization of low-titer serums with 125 I-antibody. Science. 1973 Apr 15; 180 (4082):203–205. [PubMed ]
  • Millman I, Loeb LA, Bayer ME, Blumberg BS. Australia antigen (a hepatitis-associated antigen): purification and physical properties. J Exp Med. 1970 Jun 1; 131 (6):1190–1199. [PMC free article ] [PubMed ]
  • Prince AM, Szmuness W, Woods KR, Grady GF. Antibody against serum-hepatitis antigen. Prevalence and potential use as immune serum globulin in prevention of serum-hepatitis infections. N Engl J Med. 1971 Oct 21; 285 (17):933–938. [PubMed ]
  • Purcell RH, Gerin JL, Holland PV, Cline WL, Chanock RM. Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum. J Infect Dis. 1970 Feb; 121 (2):222–226. [PubMed ]
  • Vyas GN, Shulman NR. Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science. 1970 Oct 16; 170 (3955):332–333. [PubMed ]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

Category: Disease

Similar articles: